vs
Side-by-side financial comparison of B&G Foods, Inc. (BGS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $439.3M, roughly 1.1× B&G Foods, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -4.4%, a 11.2% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -4.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -12.8%).
B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BGS vs MD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $439.3M | $493.8M |
| Net Profit | $-19.1M | $33.7M |
| Gross Margin | 22.5% | — |
| Operating Margin | 2.5% | 9.9% |
| Net Margin | -4.4% | 6.8% |
| Revenue YoY | -4.7% | -1.7% |
| Net Profit YoY | -356.5% | 10.5% |
| EPS (diluted) | $-0.24 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $493.8M | ||
| Q3 25 | $439.3M | $492.9M | ||
| Q2 25 | $424.4M | $468.8M | ||
| Q1 25 | $425.4M | $458.4M | ||
| Q4 24 | $551.6M | $502.4M | ||
| Q3 24 | $461.1M | $511.2M | ||
| Q2 24 | $444.6M | $504.3M | ||
| Q1 24 | $475.2M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $-19.1M | $71.7M | ||
| Q2 25 | $-9.8M | $39.3M | ||
| Q1 25 | $835.0K | $20.7M | ||
| Q4 24 | $-222.4M | $30.5M | ||
| Q3 24 | $7.5M | $19.4M | ||
| Q2 24 | $3.9M | $-153.0M | ||
| Q1 24 | $-40.2M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | 20.7% | — | ||
| Q1 24 | 22.9% | — |
| Q4 25 | — | 9.9% | ||
| Q3 25 | 2.5% | 13.8% | ||
| Q2 25 | 5.2% | 12.8% | ||
| Q1 25 | 8.4% | 7.0% | ||
| Q4 24 | -46.6% | 7.8% | ||
| Q3 24 | 11.1% | 6.6% | ||
| Q2 24 | 9.9% | -31.3% | ||
| Q1 24 | -3.3% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | -4.4% | 14.5% | ||
| Q2 25 | -2.3% | 8.4% | ||
| Q1 25 | 0.2% | 4.5% | ||
| Q4 24 | -40.3% | 6.1% | ||
| Q3 24 | 1.6% | 3.8% | ||
| Q2 24 | 0.9% | -30.3% | ||
| Q1 24 | -8.5% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | $-0.24 | $0.84 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $0.01 | $0.24 | ||
| Q4 24 | $-2.81 | $0.37 | ||
| Q3 24 | $0.09 | $0.23 | ||
| Q2 24 | $0.05 | $-1.84 | ||
| Q1 24 | $-0.51 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $375.2M |
| Total DebtLower is stronger | $2.0B | $570.5M |
| Stockholders' EquityBook value | $470.7M | $865.9M |
| Total Assets | $2.9B | $2.2B |
| Debt / EquityLower = less leverage | 4.30× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | $60.9M | $340.1M | ||
| Q2 25 | $54.1M | $224.7M | ||
| Q1 25 | $61.2M | $99.0M | ||
| Q4 24 | $50.6M | $229.9M | ||
| Q3 24 | $54.7M | $103.8M | ||
| Q2 24 | $40.3M | $19.4M | ||
| Q1 24 | $42.5M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $2.0B | $577.2M | ||
| Q2 25 | $2.0B | $583.9M | ||
| Q1 25 | $2.0B | $590.5M | ||
| Q4 24 | $2.0B | $597.1M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.0B | — |
| Q4 25 | — | $865.9M | ||
| Q3 25 | $470.7M | $890.7M | ||
| Q2 25 | $501.4M | $833.8M | ||
| Q1 25 | $513.1M | $789.2M | ||
| Q4 24 | $524.8M | $764.9M | ||
| Q3 24 | $755.3M | $732.5M | ||
| Q2 24 | $765.0M | $706.5M | ||
| Q1 24 | $781.2M | $856.2M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | $2.9B | $2.2B | ||
| Q2 25 | $2.9B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.2B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.4B | $2.0B | ||
| Q1 24 | $3.4B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 4.30× | 0.65× | ||
| Q2 25 | 3.97× | 0.70× | ||
| Q1 25 | 3.91× | 0.75× | ||
| Q4 24 | 3.85× | 0.78× | ||
| Q3 24 | 2.75× | — | ||
| Q2 24 | 2.67× | — | ||
| Q1 24 | 2.61× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-64.6M | $114.1M |
| Free Cash FlowOCF − Capex | $-70.7M | — |
| FCF MarginFCF / Revenue | -16.1% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $54.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.1M | ||
| Q3 25 | $-64.6M | $137.3M | ||
| Q2 25 | $17.8M | $137.2M | ||
| Q1 25 | $52.7M | $-117.5M | ||
| Q4 24 | $80.3M | $133.0M | ||
| Q3 24 | $4.2M | $91.8M | ||
| Q2 24 | $11.3M | $107.0M | ||
| Q1 24 | $35.1M | $-125.2M |
| Q4 25 | — | — | ||
| Q3 25 | $-70.7M | — | ||
| Q2 25 | $11.5M | — | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $71.7M | — | ||
| Q3 24 | $-679.0K | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $27.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | -16.1% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | -0.1% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 63.17× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 0.56× | 4.72× | ||
| Q2 24 | 2.87× | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
